ORIGIMM
Origimm is an Austrian biotechnology company, which specializes in discovery of antigens and functional drug targets.
ORIGIMM
Industry:
Biotechnology
Address:
Gerasdorf Bei Wien, Niederosterreich, Austria
Country:
Austria
Website Url:
http://www.origimm.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Sitelinks Search Box Organization Schema ReCAPTCHA
Similar Organizations
Covalab
Covalab is a biotechnology company specialised in the chemical modification of antigens and antibodies.
Current Employees Featured
Sanja (Sanya) Selak Founder, CEO, Managing Director, and CSO @ Origimm
Founder, CEO, Managing Director, and CSO
2012-08-01
Zrinka Ivezic Schoenfeld Consultant to CEO & Head Clinical Development @ Origimm
Consultant to CEO & Head Clinical Development
2020-01-01
Founder
More informations about "Origimm"
Origimm - Crunchbase Company Profile & Funding
Origimm is an Austrian biotechnology company, which specializes in discovery of antigens and functional drug targets. ... Experience the new Crunchbase, …See details»
Sanofi to acquire Origimm Biotechnology in first move to treat …
Dec 1, 2006 About Origimm. Origimm (‘Origins of Immunity’) is an Austrian biotech company with lead expertise in discovery of vaccine antigens and drug targets for prevention and …See details»
Sanofi snaps up Origimm for early-phase acne vaccine, …
Dec 1, 2021 Origimm kept a fairly low profile over its nine-year history, disclosing a series A financing in 2016 without revealing the size of the round, and additional cash from an Austrian funding scheme ...See details»
Origimm Biotechnology GmbH, a Sanofi company - Life Sciences …
Origimm (‘Origins of immunity’) is a biotech company that specializes in the discovery of antigens and dermatological drug targets. The company uses its proprietary technology that employs …See details»
Origimm Biotechnology GmbH - Drug pipelines, Patents ... - Patsnap
Jan 23, 2025 Origimm was founded by biotech industry veteran Sanja Selak, the company’s CEO and chief scientific officer. She operated the business as a sole proprietorship from 2012 …See details»
Origimm 2025 Company Profile: Valuation, Investors, …
Origimm General Information Description. Operator of a biotechnology company intended to specialize in the discovery of antigens and functional drugs. The company's offerings include the development of novel treatments that are …See details»
ORI001 - Drug Targets, Indications, Patents - Synapse
Mar 20, 2025 Origimm was founded by biotech industry veteran Sanja Selak, the company’s CEO and chief scientific officer. She operated the business as a sole proprietorship from 2012 …See details»
Sanofi acquires Origimm - 2021-12-01 - Crunchbase
Dec 1, 2021 Origimm Origimm is an Austrian biotechnology company, which specializes in discovery of antigens and functional drug targets. Acquiring Organization: Sanofi Sanofi is a …See details»
Origimm Biotechnology GmbH - VentureRadar
Origimm strives to establish itself as the leader in pioneering medical research that delivers superior products to prevent and treat skin microbiome-associated diseases. Origimm …See details»
Origimm - Crunchbase
Origimm is an Austrian biotechnology company, which specializes in discovery of antigens and functional drug targets.See details»
Origimm Company Profile - Office Locations, Competitors ... - Craft
Origimm is a company developing therapeutic solutions for the immune regulation and treatment of the skin microbiome-associated diseases. It provides products against the skin colonizing …See details»
Sanofi to buy Origimm Biotechnology for acne vaccine candidate
Dec 1, 2021 French healthcare company Sanofi said on Wednesday it would buy Austrian group Origimm Biotechnology, a move that will add a potential first-in-class vaccine candidate to …See details»
Sanofi group company Origimm Biotechnology initiates First-in …
Dec 22, 2021 Origimm, an Austrian biotech company specializing in discovering the origins of the protective immune response for the development of breakthrough therapies, ... As a life …See details»
Sanofi snaps up acne vaccine developer Origimm Bio
6 days ago Origimm's expertise in the skin microbiome and antigen discovery will be central to that effort, it added. Acne affects millions of people around the world, and while it is often a …See details»
Origimm - Contacts, Employees, Board Members, Advisors & Alumni
Origimm is an Austrian biotechnology company, which specializes in discovery of antigens and functional drug targets. New. ... Log In. Experience the new Crunchbase, powered by AI . …See details»
Sanofi to acquire Origimm Biotechnology in first move to
Dec 1, 2021 Origimm (‘Origins of Immunity’) is an Austrian biotech company with lead expertise in discovery of vaccine antigens and drug targets for prevention and treatment of diseases and …See details»
Sanofi to Acquire Origimm Biotechnology for Vaccine-based
Dec 9, 2021 “The acquisition of Origimm further broadens our vaccines R&D pipeline with a first vaccine candidate against acne, a high medical need for millions of teenagers and adults,” …See details»
Implant-associated infection vaccine - Origimm - AdisInsight
Origimm (a subsidiary of Sanofi) is developing a vaccine for the prevention of Propionibacterium acnes implant-associated infections, using its ProVaDis ... If your organization has a …See details»
Sanofi to acquire Origimm Biotechnology in first move to treat …
Dec 1, 2021 Sanofi announced today it entered into an agreement to acquire Origimm Biotechnology GmbH, an Austrian privately owned biotechnology company specializing in the …See details»
Heritage Calgary CEO Josh Traptow to depart organization next …
17 hours ago After 10 years of helping tell the city's history, Heritage Calgary's CEO is set to depart the civic partner organization next month.See details»